Advance Solid Tumors Clinical Trials

8 clinical trials for Advance Solid Tumors across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-8989 in Patients With Advanced Solid Tumors Harboring KRAS G12D Mutations — RECRUITING · PHASE1
• Phase I/Ib clinical trial of PM54 in Advance Solid Tumors patients — RECRUITING · PHASE2
• A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors — RECRUITING · PHASE1
• A first-in-human, Phase 1/2, open-label, multi-center, dose-escalation, dose-optimization, and dose-expansion study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and antitumor activity of PARP1-selective inhibitor, EIK1003 (IMP1734), as monotherapy and in combination in participants with advanced solid tumors. — TERMINATED · PHASE2
• A Phase 1/2a, Open-label, Dose-finding Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of BMS-986507 (BL-B01D1) combinations in Adult Participants with Advanced Solid Tumors — TERMINATED · PHASE2
• A Study of CS231295 in Patients With Advanced Solid Tumors — NOT_YET_RECRUITING · PHASE1
• A First-in-Human Study of ALK-N001 for Injection in Patients With Advanced Solid Tumors — SUSPENDED · PHASE1
• Safety and Pharmacokinetics of SAR240550 (BSI-201) Twice Weekly in Patients With Advanced Solid Tumors — COMPLETED · PHASE1

Refine this search